{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:38:00Z","timestamp":1770813480548,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2024QH374"],"award-info":[{"award-number":["ZR2024QH374"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36272-0","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:03:56Z","timestamp":1768799036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["D-mannose alleviates rotenone-induced PD mouse model through microbiota-gut-brain axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Yan","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"10291","key":"36272_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397 (10291), 2284\u20132303 (2021).","journal-title":"Lancet"},{"issue":"10","key":"36272_CR2","doi-asserted-by":"publisher","first-page":"E551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl, G. et al. The burden of neurological diseases in Europe: An analysis for the global burden of disease study 2017. Lancet Public. Health. 5 (10), E551\u2013E67 (2020).","journal-title":"Lancet Public. Health"},{"issue":"4","key":"36272_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 79 (4), 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosur Ps."},{"key":"36272_CR4","doi-asserted-by":"crossref","unstructured":"Caputi, V. & Giron, M. C. Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s Disease. Int. J. Mol. Sci. 19(6). (2018).","DOI":"10.3390\/ijms19061689"},{"issue":"6","key":"36272_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach, T. G. et al. Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with lewy body disorders. Acta Neuropathol. 119 (6), 689\u2013702 (2010).","journal-title":"Acta Neuropathol."},{"issue":"2","key":"36272_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma, M. & Burre, J. alpha-Synuclein in synaptic function and dysfunction. Trends Neurosci. 46 (2), 153\u2013166 (2023).","journal-title":"Trends Neurosci."},{"issue":"3","key":"36272_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Protein-protein interactions regulating alpha-synuclein pathology. Trends Neurosci. 47 (3), 209\u2013226 (2024).","journal-title":"Trends Neurosci."},{"issue":"9","key":"36272_CR8","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Novel compound FLZ alleviates rotenoneinduced PD mouse model by suppressing TLR4\/ MyD88\/NF-\u03baB pathway through microbiotaegutebrain axis. Acta Pharm. Sin B. 11 (9), 2859\u20132879 (2021).","journal-title":"Acta Pharm. Sin B"},{"issue":"6","key":"36272_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E. & Pfeiffer, R. F. Gastrointestinal dysfunction in parkinson\u2019s disease. Lancet Neurol. 14 (6), 625\u2013639 (2015).","journal-title":"Lancet Neurol."},{"issue":"6","key":"36272_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/boc.201800068","volume":"111","author":"A Martinez","year":"2019","unstructured":"Martinez, A., Lopez, N., Gonzalez, C. & Hetz, C. Targeting of the unfolded protein response (UPR) as therapy for parkinson\u2019s disease. Biol. Cell. 111 (6), 161\u2013168 (2019).","journal-title":"Biol. Cell."},{"key":"36272_CR11","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.3233\/JPD-181487","volume":"8","author":"AS Chen-Plotkin","year":"2018","unstructured":"Chen-Plotkin, A. S. & Zetterberg, H. Updating our definitions of parkinson\u2019s disease for a molecular age. J. Parkinson Dis. 8, S53\u2013S7 (2018).","journal-title":"J. Parkinson Dis."},{"issue":"1","key":"36272_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S. & Li-Hua, P. Signaling pathways in parkinson\u2019s disease: Molecular mechanisms and therapeutic interventions. Signal. Transduct. Target. Ther. 8 (1), 73 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"36272_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nn.3350","volume":"16","author":"SJ Orenstein","year":"2013","unstructured":"Orenstein, S. J. et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16 (4), 394\u2013U52 (2013).","journal-title":"Nat. Neurosci."},{"issue":"11","key":"36272_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","volume":"16","author":"JC Latourelle","year":"2017","unstructured":"Latourelle, J. C. et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed parkinson\u2019s disease: a longitudinal cohort study and validation. Lancet Neurol. 16 (11), 908\u2013916 (2017).","journal-title":"Lancet Neurol."},{"key":"36272_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuro.2018.12.009","volume":"71","author":"S Bhurtel","year":"2019","unstructured":"Bhurtel, S., Katila, N., Srivastav, S., Neupane, S. & Choi, D. Y. Mechanistic comparison between MPTP and rotenone neurotoxicity in mice. Neurotoxicology 71, 113\u2013121 (2019).","journal-title":"Neurotoxicology"},{"issue":"1","key":"36272_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","volume":"19","author":"FF Geibl","year":"2024","unstructured":"Geibl, F. F. et al. alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease. Mol. Neurodegener. 19 (1), 69 (2024).","journal-title":"Mol. Neurodegener"},{"key":"36272_CR17","doi-asserted-by":"crossref","unstructured":"Plagnol, V. et al. A two-stage meta-analysis identifies several new loci for Parkinson\u2019s disease. Plos Genet. 7(6). (2011).","DOI":"10.1371\/journal.pgen.1002142"},{"issue":"21","key":"36272_CR18","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang, J. et al. Gut-induced alpha-Synuclein and Tau propagation initiate parkinson\u2019s and alzheimer\u2019s disease co-pathology and behavior impairments. Neuron 112 (21), 3585\u20133601 (2024). e5.","journal-title":"Neuron"},{"key":"36272_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2023","unstructured":"Salim, S., Ahmad, F., Banu, A. & Mohammad, F. Gut Microbiome and parkinson\u2019s disease: perspective on pathogenesis and treatment. J. Adv. Res. 50, 83\u2013105 (2023).","journal-title":"J. Adv. Res."},{"issue":"11","key":"36272_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer, L. & Reichmann, H. Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat. Rev. Neurol. 11 (11), 625\u2013636 (2015).","journal-title":"Nat. Rev. Neurol."},{"issue":"37","key":"36272_CR21","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak, A. & Bonaz, B. Brain-gut-microbiota axis in Parkinson\u2019s disease. World J. Gastroenterol. 21 (37), 10609\u201310620 (2015).","journal-title":"World J. Gastroentero"},{"issue":"9","key":"36272_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/jnen\/nlab046","volume":"80","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. Electroacupuncture alleviates neuroinflammation and motor dysfunction by regulating intestinal barrier function in a mouse model of Parkinson disease. J. Neuropathol. Exp. Neur. 80 (9), 844\u2013855 (2021).","journal-title":"J. Neuropath Exp. Neur"},{"issue":"10","key":"36272_CR23","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.4103\/1673-5374.391304","volume":"19","author":"PM Neufeld","year":"2024","unstructured":"Neufeld, P. M. et al. Unraveling the gut-brain axis: The impact of steroid hormones and nutrition on parkinson\u2019s disease. Neural Regen. Res. 19 (10), 2219\u20132228 (2024).","journal-title":"Neural Regen Res."},{"key":"36272_CR24","doi-asserted-by":"crossref","unstructured":"Mohapatra, L., Mishra, D., Tripathi, A. S. & Parida, S. K. Immunosenescence as a convergence pathway in neurodegeneration. Int. Immunopharmacol. 121. (2023).","DOI":"10.1016\/j.intimp.2023.110521"},{"key":"36272_CR25","doi-asserted-by":"crossref","unstructured":"Elangovan, A. et al. Does gut brain axis has an impact on Parkinson\u2019s disease (PD)? Ageing Res. Rev. 94. (2024).","DOI":"10.1016\/j.arr.2023.102171"},{"issue":"11","key":"36272_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/tx049867r","volume":"17","author":"P Caboni","year":"2004","unstructured":"Caboni, P. et al. Rotenone, deguelin, their metabolites, and the rat model of parkinson\u2019s disease. Chem. Res. Toxicol. 17 (11), 1540\u20131548 (2004).","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"36272_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner, C. M. et al. Rotenone, Paraquat, and parkinson\u2019s disease. Environ. Health Persp. 119 (6), 866\u2013872 (2011).","journal-title":"Environ. Health Persp"},{"key":"36272_CR28","doi-asserted-by":"crossref","unstructured":"Pan-Montojo, F. et al. Progression of Parkinson\u2019s Disease pathology is reproduced by intragastric administration of rotenone in mice. Plos One ;5(1). (2010).","DOI":"10.1371\/journal.pone.0008762"},{"issue":"6","key":"36272_CR29","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden, M. et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J. Neurochem. 101 (6), 1491\u20131504 (2007).","journal-title":"J. Neurochem"},{"key":"36272_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson, M. E. & Bobrovskaya, L. An update on the rotenone models of parkinson\u2019s disease: Their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 46, 101\u2013116 (2015).","journal-title":"Neurotoxicology"},{"key":"36272_CR31","doi-asserted-by":"crossref","unstructured":"Yang, X. D., Qian, Y. W., Xu, S. Q., Song, Y. Y. & Xiao, Q. Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s Disease. Front. Aging Neurosci. 9 (2018).","DOI":"10.3389\/fnagi.2017.00441"},{"key":"36272_CR32","doi-asserted-by":"crossref","unstructured":"Zhang, X. Y., Molsberry, S. A., Schwarzschild, M. A., Ascherio, A. & Gao, X. Association of diet and physical activity with All-Cause mortality among adults with Parkinson disease. Jama Netw. Open. 5(8):e2227738. (2022).","DOI":"10.1001\/jamanetworkopen.2022.27738"},{"issue":"5","key":"36272_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner, C. M. & Ostrem, J. L. Parkinson\u2019s disease. New. Engl. J. Med. 391 (5), 442\u2013452 (2024).","journal-title":"New. Engl. J. Med."},{"issue":"10423","key":"36272_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. Parkinson\u2019s disease 2 the pathogenesis of parkinson\u2019s disease. Lancet 403 (10423), 293\u2013304 (2024).","journal-title":"Lancet"},{"issue":"9","key":"36272_CR35","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl, G. et al. European academy of Neurology\/Movement disorder Society - European section guideline on the treatment of parkinson\u2019s disease: I. Invasive therapies. Eur. J. Neurol. 29 (9), 2580\u20132595 (2022).","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"36272_CR36","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1074\/jbc.M113.544064","volume":"289","author":"M Ichikawa","year":"2014","unstructured":"Ichikawa, M., Scott, D. A., Losfeld, M. E. & Freeze, H. H. The metabolic origins of mannose in glycoproteins. J. Biol. Chem. 289 (10), 6751\u20136761 (2014).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"36272_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/1541-4337.12211","volume":"15","author":"X Hu","year":"2016","unstructured":"Hu, X. et al. d-Mannose: Properties, Production, and applications: an overview. Compr. Rev. Food Sci. F. 15 (4), 773\u2013785 (2016).","journal-title":"Compr. Rev. Food Sci. F"},{"key":"36272_CR38","doi-asserted-by":"publisher","unstructured":"Cooper, T. E. et al. D-mannose for preventing and treating urinary tract infections. Cochrane Db Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD013608.pub2 (2022).","DOI":"10.1002\/14651858.CD013608.pub2"},{"key":"36272_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1073\/pnas.2107663118","volume":"118","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. D-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation. Proc. Natl. Acad. Sci. USA. 118, 44 (2021).","journal-title":"P Natl. Acad. Sci. USA"},{"key":"36272_CR40","doi-asserted-by":"publisher","first-page":"1365457","DOI":"10.3389\/fimmu.2024.1365457","volume":"15","author":"Y. Yang","year":"2024","unstructured":"Yang, Y. et al. Mannose enhances intestinal immune barrier function and dextran sulfate sodium salt-induced colitis in mice by regulating intestinal microbiota. Front. Immunol. 15, 1365457 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"36272_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12967-022-03870-1","volume":"21","author":"R Gu","year":"2023","unstructured":"Gu, R. et al. D-Mannose prevents bone loss under weightlessness. J. Transl Med. 21 (1), 8 (2023).","journal-title":"J. Transl Med."},{"key":"36272_CR42","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp, K. O., Glotfelty, E. J., Li, Y. & Greig, N. H. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol. Res. 186, 106550 (2022).","journal-title":"Pharmacol. Res."},{"key":"36272_CR43","doi-asserted-by":"publisher","first-page":"102089","DOI":"10.1016\/j.pneurobio.2021.102089","volume":"204","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Lachance, B. B., Mattson, M. P. & Jia, X. Glucose metabolic crosstalk and regulation in brain function and diseases. Prog Neurobiol. 204, 102089 (2021).","journal-title":"Prog Neurobiol."},{"key":"36272_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh, B., Day, C. M., Abdella, S. & Garg, S. Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J. Control Release. 367, 402\u2013424 (2024).","journal-title":"J. Control Release"},{"issue":"6","key":"36272_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth, H. D. E., Hirst, W. D. & Wade-Martins, R. The role of astrocyte dysfunction in parkinson\u2019s disease pathogenesis. Trends Neurosci. 40 (6), 358\u2013370 (2017).","journal-title":"Trends Neurosci."},{"issue":"10","key":"36272_CR46","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s11427-016-5083-9","volume":"59","author":"X Hu","year":"2016","unstructured":"Hu, X., Wang, T. & Jin, F. Alzheimer\u2019s disease and gut microbiota. Sci. China Life Sci. 59 (10), 1006\u20131023 (2016).","journal-title":"Sci. China Life Sci."},{"key":"36272_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun, M. F. & Shen, Y. Q. Dysbiosis of gut microbiota and microbial metabolites in parkinson\u2019s disease. Ageing Res. Rev. 45, 53\u201361 (2018).","journal-title":"Ageing Res. Rev."},{"key":"36272_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z. Zhao","year":"2021","unstructured":"Zhao, Z. et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9, 226 (2021).","journal-title":"Microbiome"},{"issue":"3","key":"36272_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai, B. S., Monahan, A. J., Carvey, P. M. & Hendey, B. Blood-brain barrier pathology in alzheimer\u2019s and parkinson\u2019s disease: implications for drug therapy. Cell. Transpl. 16 (3), 285\u2013299 (2007).","journal-title":"Cell. Transpl."},{"issue":"3","key":"36272_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"XQ Yang","year":"2020","unstructured":"Yang, X. Q., Yu, D. K., Xue, L., Li, H. & Du, J. R. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin B. 10 (3), 475\u2013487 (2020).","journal-title":"Acta Pharm. Sin B"},{"issue":"3","key":"36272_CR51","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1111\/nmo.12070","volume":"25","author":"M Tasselli","year":"2013","unstructured":"Tasselli, M. et al. Effects of oral administration of rotenone on Gastrointestinal functions in mice. Neurogastroent Motil. 25 (3), E183\u2013E93 (2013).","journal-title":"Neurogastroent Motil."},{"key":"36272_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41575-023-00890-0","volume":"21","author":"M. R. Aburto","year":"2024","unstructured":"Aburto, M. R. & Cryan, J. F. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis. Nat. Rev. Gastro Hepat. 21, 222 (2024).","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"36272_CR53","doi-asserted-by":"publisher","first-page":"114308","DOI":"10.1016\/j.biopha.2023.114308","volume":"160","author":"H. L. Wei","year":"2023","unstructured":"Wei, H. L. et al. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis. Biomed. Pharmacother. 160, 114308 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"36272_CR54","doi-asserted-by":"publisher","first-page":"155254","DOI":"10.1016\/j.phymed.2023.155254","volume":"126","author":"M. J. Mao","year":"2024","unstructured":"Mao, M. J. et al. Neuroprotection of rhubarb extract against cerebral ischaemia-reperfusion injury via the gut-brain axis pathway. Phytomedicine 126, 155254 (2024).","journal-title":"Phytomedicine"},{"issue":"5","key":"36272_CR55","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo, P. et al. Role of TLR4 in the gut-brain axis in parkinson\u2019s disease: a translational study from men to mice. Gut 68 (5), 829\u2013843 (2019).","journal-title":"Gut"},{"key":"36272_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun, M. F. et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced parkinson\u2019s disease mice: gut microbiota, glial reaction and TLRLI\/TNF-\u03b1 signaling pathway. Brain Behav. Immun. 70, 48\u201360 (2018).","journal-title":"Brain Behav. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36272-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:03:23Z","timestamp":1770764603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36272-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36272"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36272-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We conducted animal experiments according to International Guiding Principle for Animal Research that was stipulated by Council for International Organizations of Medical Sciences (CIOMS), the routines have obtained approval from Shandong Provincial Hospital Affiliated to Shandong First Medical University Animal Ethics Committee. The participants working with animal model received training abiding by the rules of Institutional Animal Care and Use Committee Guidebook (IACUC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This article does not contain any individual person\u2019s data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"5680"}}